175 related articles for article (PubMed ID: 36700771)
1. Insights into the drug screening approaches in leishmaniasis.
Gopu B; Kour P; Pandian R; Singh K
Int Immunopharmacol; 2023 Jan; 114():109591. PubMed ID: 36700771
[TBL] [Abstract][Full Text] [Related]
2. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
Jain SK; Sahu R; Walker LA; Tekwani BL
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
[TBL] [Abstract][Full Text] [Related]
3. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
[TBL] [Abstract][Full Text] [Related]
4. Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds.
Corman HN; Shoue DA; Norris-Mullins B; Melancon BJ; Morales MA; McDowell MA
Int J Antimicrob Agents; 2019 Oct; 54(4):496-501. PubMed ID: 31323307
[TBL] [Abstract][Full Text] [Related]
5. Leishmaniasis drug discovery: recent progress and challenges in assay development.
Zulfiqar B; Shelper TB; Avery VM
Drug Discov Today; 2017 Oct; 22(10):1516-1531. PubMed ID: 28647378
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.
Ortiz D; Guiguemde WA; Hammill JT; Carrillo AK; Chen Y; Connelly M; Stalheim K; Elya C; Johnson A; Min J; Shelat A; Smithson DC; Yang L; Zhu F; Guy RK; Landfear SM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006157. PubMed ID: 29287089
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
8. Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic Potential.
Kwofie SK; Broni E; Dankwa B; Enninful KS; Kwarko GB; Darko L; Durvasula R; Kempaiah P; Rathi B; Miller Iii WA; Yaya A; Wilson MD
Curr Top Med Chem; 2020; 20(5):349-366. PubMed ID: 31994465
[TBL] [Abstract][Full Text] [Related]
9. An ex vivo multiparametric flow cytometry assay using human whole blood to simultaneously measure cytotoxicity and leishmanicidal activities.
Ribeiro JM; Bandeira CC; de Faria BG; Alves MLR; Vieira FO; Giunchetti RC; Uzonna JE; Teixeira-Carvalho A; Peruhype-Magalhães V; Souza-Fagundes EM
Exp Parasitol; 2020 Sep; 216():107940. PubMed ID: 32562606
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds.
Siqueira-Neto JL; Song OR; Oh H; Sohn JH; Yang G; Nam J; Jang J; Cechetto J; Lee CB; Moon S; Genovesio A; Chatelain E; Christophe T; Freitas-Junior LH
PLoS Negl Trop Dis; 2010 May; 4(5):e675. PubMed ID: 20454559
[TBL] [Abstract][Full Text] [Related]
11. Assay development in leishmaniasis drug discovery: a comprehensive review.
Zulfiqar B; Avery VM
Expert Opin Drug Discov; 2022 Feb; 17(2):151-166. PubMed ID: 34818139
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics.
Borsari C; Jiménez-Antón MD; Eick J; Bifeld E; Torrado JJ; Olías-Molero AI; Corral MJ; Santarem N; Baptista C; Severi L; Gul S; Wolf M; Kuzikov M; Ellinger B; Reinshagen J; Witt G; Linciano P; Tait A; Costantino L; Luciani R; Tejera Nevado P; Zander-Dinse D; Franco CH; Ferrari S; Moraes CB; Cordeiro-da-Silva A; Ponterini G; Clos J; Alunda JM; Costi MP
Eur J Med Chem; 2019 Dec; 183():111676. PubMed ID: 31542713
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Clustering Analysis as a Strategy for Compound Selection in the Drug Discovery Pipeline for Leishmaniasis.
Armitage EG; Godzien J; Peña I; López-Gonzálvez Á; Angulo S; Gradillas A; Alonso-Herranz V; Martín J; Fiandor JM; Barrett MP; Gabarro R; Barbas C
ACS Chem Biol; 2018 May; 13(5):1361-1369. PubMed ID: 29671577
[TBL] [Abstract][Full Text] [Related]
14. Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level.
González-Matos M; Aguado ME; Izquierdo M; Monzote L; González-Bacerio J
Exp Parasitol; 2024 May; 260():108747. PubMed ID: 38518969
[TBL] [Abstract][Full Text] [Related]
15. Current approaches to discover marine antileishmanial natural products.
Tempone AG; Martins de Oliveira C; Berlinck RG
Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
[TBL] [Abstract][Full Text] [Related]
16. Advancement in leishmaniasis diagnosis and therapeutics: An update.
Kumari D; Perveen S; Sharma R; Singh K
Eur J Pharmacol; 2021 Nov; 910():174436. PubMed ID: 34428435
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptides for leishmaniasis.
Cobb SL; Denny PW
Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
[TBL] [Abstract][Full Text] [Related]
18. In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin.
Khanra S; Kumar YP; Dash J; Banerjee R
BMC Res Notes; 2018 May; 11(1):319. PubMed ID: 29784022
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs.
Pulido SA; Muñoz DL; Restrepo AM; Mesa CV; Alzate JF; Vélez ID; Robledo SM
Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571
[TBL] [Abstract][Full Text] [Related]
20. Drug search for leishmaniasis: a virtual screening approach by grid computing.
Ochoa R; Watowich SJ; Flórez A; Mesa CV; Robledo SM; Muskus C
J Comput Aided Mol Des; 2016 Jul; 30(7):541-52. PubMed ID: 27438595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
